Related Experiment Videos

[Treatment of chronic hepatitis C patients complicated with the other disease]

T Kawabe1, G Toda

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 10, 2001
PubMed

Insights

Hepatitis C virus (HCV) treatment in patients with other diseases is poorly understood. Treatment may be indicated if the other condition is controlled, prioritizing liver function and long-term survival.

Area of Science:

  • Hepatology
  • Virology
  • Internal Medicine

Context:

  • Hepatitis C virus (HCV) patients with comorbidities like hematologic disorders, chronic renal failure, HIV, or collagen disease are often excluded from clinical trials.
  • Limited data exists on the efficacy and safety of standard HCV therapies (interferon/ribavirin) in these complex patient populations.

Purpose:

  • To review existing literature on HCV treatment strategies for patients with significant comorbidities.
  • To provide evidence-based recommendations for initiating HCV therapy in these challenging cases, considering tolerance and efficacy.

Summary:

  • Analysis of medical literature suggests that HCV treatment may be beneficial for patients with well-controlled comorbidities and expected long-term survival.
  • Treatment decisions should be guided by thorough evaluation of liver function tests and liver pathology to prevent advanced liver disease.

Impact:

  • Highlights the need for tailored HCV treatment approaches in patients with co-existing medical conditions.
  • Emphasizes the importance of further research to establish optimal therapeutic guidelines for this understudied patient group.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...